Daklinza troubled with the September launch of Sovaldi

It seems that a domestic approval of the hepatitis type C treatment, ‘Sovaldi(generic name: sofosbuvir),’ will be made between September and October. As the approval of Sovaldi has come closer, BMS Korea has also been impatient.

A person in Gilead Sciences has recently unveiled that the Ministry of Food and Drug Safety will approve Sovaldi on September or October, at the latest.

By the entry ...